
Lincoln Park Capital Fund
Description
Lincoln Park Capital Fund, LLC is a Chicago-based institutional investor specializing in providing flexible capital solutions to public and private companies. Established in 1995, the firm has built a reputation for its opportunistic investment approach, primarily focusing on growth-oriented small-cap and micro-cap companies across various sectors, including biotechnology, healthcare, technology, and consumer products. Unlike traditional venture capital firms that typically invest in early-stage private companies, Lincoln Park Capital's core expertise lies in navigating the public markets, offering a distinct financing alternative for companies seeking capital without the complexities of traditional debt or equity offerings.
The firm's primary investment vehicles include Private Investments in Public Equity (PIPEs), registered direct offerings, and equity line facilities. These structures allow companies to access capital on an as-needed basis, providing a flexible and often less dilutive alternative to conventional financing rounds. Lincoln Park Capital positions itself as a long-term financial partner, offering capital for purposes such as working capital, research and development, product commercialization, and strategic acquisitions. Their strategy is particularly appealing to companies that require ongoing access to capital to fund their growth initiatives and operational needs in a dynamic market environment.
Based on their publicly disclosed transactions, Lincoln Park Capital Fund typically commits substantial capital. For instance, observed equity line facilities and purchase agreements range significantly, with commitments as low as $10 million for certain common stock purchase agreements and extending up to $100 million for larger equity line facilities. These figures represent the maximum amount of capital a company can draw down under the agreement, reflecting Lincoln Park Capital's capacity to deploy significant funds. The firm's ability to tailor these agreements to the specific needs of each company underscores its flexible and partnership-oriented approach to investing.
Lincoln Park Capital's model emphasizes providing efficient and timely access to capital, enabling companies to focus on their core business objectives rather than protracted fundraising efforts. Their deep understanding of public market dynamics allows them to structure deals that align with the long-term growth strategies of their portfolio companies. As a consistent provider of capital, Lincoln Park Capital Fund plays a crucial role in supporting the growth and development of emerging public companies in the United States.
Investor Profile
Lincoln Park Capital Fund has backed more than 32 startups, with 1 new investments in the last 12 months alone. The firm has led 22 rounds, about 69% of its total and boasts 29 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Post Ipo Equity, Post Ipo Secondary, Private Equity rounds (top funding stages).
- Majority of deals are located in United States, Canada, Denmark.
- Strong thematic focus on Biotechnology, Health Care, Pharmaceutical.
- Led 1 rounds in the past year.
- Typical check size: $10M – $100M.
Stage Focus
- Post Ipo Equity (91%)
- Post Ipo Secondary (3%)
- Private Equity (3%)
- Seed (3%)
Country Focus
- United States (88%)
- Canada (9%)
- Denmark (3%)
Industry Focus
- Biotechnology
- Health Care
- Pharmaceutical
- Therapeutics
- Medical
- Biopharma
- Oncology
- Cleantech
- Wellness
- Life Science
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.